Estrella Immunopharma, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
ESLA Nasdaq 2830 www.estrellabio.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Estrella Immunopharma, Inc.

Spotlight On US Penny Stocks: Estrella Immunopharma And Two Others To Consider - Nov 14th, 2024 8:05 pm
Estrella Immunopharma Achieves Complete Response in First Patient Treated with CD19- Redirected ARTEMIS® T-cells - Sep 27th, 2024 4:00 pm
Estrella Immunopharma Announces Appointment of Hong Zhang as Chairperson and Board Member - Aug 14th, 2024 4:00 pm